The Application of Pyrrolo[2, 3-d]pyrimidine Scaffold in Medicinal Chemistry from 2017 to 2021

Mini Rev Med Chem. 2023;23(10):1118-1136. doi: 10.2174/1389557523666230111161810.

Abstract

The application of privileged structures in drug design is an effective strategy, which usually leads to innovative hits/leads and successful structural optimization. Pyrrolo[2, 3- d]pyrimidine are such a scaffold which are frequently used in many clinical drugs. The biocompounds bearing pyrrolo[2, 3-d]pyrimidine skeleton show different pharmacological effects such as anti-neurodegenerative, anti-inflammatory, antibacterial, and antitumor activities. In this article, we reviewed the representative structures and biological characteristics of reported synthetic pyrrolo[2, 3-d]pyrimidine compounds from 2017 to 2021. The linked diseases and targets were also mentioned briefly. This work might provide a reference for the subsequent drug discovery based on pyrrolo[2, 3-d]pyrimidine scaffold.

Keywords: 3-d]pyrimidine; IKKs; NIK; Pyrrolo[2; anti-inflammatory; antibacterial; antitumor activities.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Chemistry, Pharmaceutical*
  • Drug Design
  • Drug Discovery
  • Pyrimidines / chemistry
  • Pyrimidines / pharmacology
  • Pyrroles / chemistry
  • Pyrroles / pharmacology
  • Structure-Activity Relationship

Substances

  • Pyrimidines
  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Pyrroles